When can I expect to return to baseline mood after starting mirtazapine 7.5 mg nightly two nights ago?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Timeline for Feeling "Back to Normal" on Mirtazapine 7.5mg

You should expect to notice initial improvements in sleep and anxiety within 1-2 weeks, but full return to baseline mood typically takes 4-6 weeks, with maximum benefit often not achieved until 6-8 weeks of treatment.

Early Response Timeline (First 2 Weeks)

The good news is that mirtazapine has a faster onset of action compared to SSRIs 1. Based on clinical trial data:

  • Week 1: You may notice improved sleep quality and reduced anxiety symptoms first. Research shows mirtazapine demonstrates significant improvement as early as 1 week after starting treatment 2, 3, 4.

  • Week 2: By the end of week 2, approximately 25% of patients experience remission of insomnia symptoms, though only 7% show full depression remission at this point 5. The maximum rate of change in depressive symptoms occurs within the first 2 weeks 2.

Critical clinical point: If you show significant improvement within the first 2 weeks, this is highly predictive of your final response 2. Conversely, if you see minimal improvement by week 2, your clinician should consider dose adjustment.

Full Response Timeline (4-8 Weeks)

  • Week 4-6: This is when most patients achieve meaningful response. Clinical trials establishing mirtazapine's efficacy used 6-week treatment periods 6.

  • Week 6: By this point, approximately 62% of patients achieve insomnia remission and 41% achieve depression remission 5.

  • Steady state: Mirtazapine reaches steady-state plasma levels within 5 days 6, but clinical response lags behind pharmacokinetic steady state.

Important Caveats About Your 7.5mg Dose

Your current dose of 7.5mg is below the therapeutic range. The FDA-approved dosing starts at 15mg/day, with a typical therapeutic range of 15-45mg/day 6. At 7.5mg, you're receiving a sub-therapeutic dose that may provide:

  • Sedation and sleep improvement (due to H1 histamine receptor antagonism)
  • Minimal antidepressant effect

Paradoxically, increased sedation is actually more common at sub-therapeutic doses (<15mg), and substantially fewer patients report sedation when using appropriate doses (≥15mg) from the start 4.

What to Expect Next

If your prescriber intends to treat depression (not just insomnia), expect them to increase your dose to at least 15mg. Once at therapeutic dosing:

  • Initial improvements: 1-2 weeks
  • Meaningful response: 4-6 weeks
  • Maximum benefit: 6-8 weeks

The 38% of patients who don't respond to any second-generation antidepressant by 6-12 weeks, and 54% don't achieve full remission 1, so if you're not improving adequately by 6 weeks at therapeutic doses, medication adjustment is warranted.

Related Questions

What is the recommended starting dose, titration schedule, and monitoring for mirtazapine in a patient using it to treat anxiety, restlessness, and insomnia?
What is the recommended starting dose, titration schedule, contraindications, side effects, and monitoring for mirtazapine in an adult with major depressive disorder, especially when insomnia is a primary symptom?
How soon after initiating mirtazapine does sedation typically occur?
What is the proper dosing and administration schedule for mirtazapine?
Does mirtazapine cause anticholinergic effects and dry mouth, and what as‑needed (PRN) anti‑anxiety medication can be used?
What is the recommended dosing and titration schedule for an adult treated with methylphenidate extended‑release (ER) up to a total daily dose of 72 mg?
What is the recommended dosing regimen of high-dose methylprednisolone for an acute multiple sclerosis relapse?
How should I evaluate an adult with a recent or ongoing dental infection requiring a root canal who now presents with headache, fever, neck stiffness or focal neurologic deficits for possible brain infection?
What are the characteristic brain MRI findings of multiple sclerosis and how should they be evaluated and managed?
In a patient with constipation currently taking docusate who presents with abdominal pain (and possible nausea), how should I manage the bowel regimen and analgesia?
What COVID‑19 treatment is recommended for an adult with stage 4 chronic kidney disease (eGFR 15–29 mL/min/1.73 m²) who has confirmed infection and is within the early‑treatment window?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.